MCU-88156-16702 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-18
Dose 1 — Moderna
2021-04-19
Dose 2 — Moderna
2021-12-28
Dose 3 — Moderna
2021-12-30
Registered in v-safe
2022-01-11
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2022-01-20
Survey response — day 21, dose 3
MedDRA: Nasal congestion, Nasopharyngitis, Sneezing — Feeling: Fair

Free text: Cold. Stuffy nose and sneezing.

MedDRA releases: 2024-11 · check-in free text available
2022-01-25
Survey response — day 28, dose 3
MedDRA: Nasal congestion, Nasopharyngitis — Feeling: Fair

Free text: Stuffy nose, cold.

MedDRA releases: 2024-11 · check-in free text available
2022-02-01
Survey response — day 35, dose 3
MedDRA: Headache, Nasal congestion, Nausea — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Stuffy nose, headache, nausea

MedDRA releases: 2024-11 · check-in free text available
2022-02-01
Report sent to call center — day 35, dose 3
Be unable to work or attend school · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-02-03
Call 1 — Left Voicemail
2022-02-08
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-03-29
Survey response — 3 months, dose 3
MedDRA: Headache, Pain, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Fever, headache and body aches

MedDRA releases: 2024-11 · check-in free text available
2022-03-29
Report sent to call center — 3 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-03-31
Call 1 — Left Voicemail
2022-06-28
Survey response — 6 months, dose 3
MedDRA: Asthma, Chest discomfort — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Tightness in chest. Asthma

MedDRA releases: 2024-11 · check-in free text available
2022-12-28
Health check-in — 12 months, dose 3
Feeling: Fair

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-18	Moderna	No
2	2021-04-19	Moderna	No
3	2021-12-28	Moderna	No

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 10 — day 21, dose 3

2022-01-20

Symptoms: Cold. Stuffy nose and sneezing.

Release 11 — day 28, dose 3

2022-01-25

Symptoms: Stuffy nose, cold.

Release 11 — day 35, dose 3

2022-02-01

Symptoms: Stuffy nose, headache, nausea

Release 11 — 3 months, dose 3

2022-03-29

Symptoms: Fever, headache and body aches

Release 12 — 6 months, dose 3

2022-06-28

Symptoms: Tightness in chest. Asthma

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Asthma	·	·	✓
SD	Chest discomfort	·	·	✓
SD	Headache	·	·	✓
SD	Nasal congestion	·	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Nausea	·	·	✓
SD	Pain	·	·	✓
SD	Pyrexia	·	·	✓
SD	Sneezing	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release